Concordia Pharmaceuticals Inc. is the trusted pharmaceutical entity that manufactures, markets and distributes more than 14 drugs in the United States. The company is an international specialty pharmaceutical company with a wide variety of pharmaceutical portfolio of more than 200 patented and off-patent products.

The company offers these products in more than 90 countries. Additionally, the company is focused on innovating, shaping and growing the specialty, off-patent sector in Europe. The company operates out of facilities in Mississauga, Ontario, and its subsidiaries, operate out of facilities in Bridgetown, Barbados; London, England, and Mumbai, India.

The parent company of Concordia Pharmaceuticals Inc. is Advanz Pharma is a rapidly growing pharmaceutical development company that dedicates its efforts to bring its portfolio of niche medications to people in over 100 countries across the world.

Concordia Pharmaceuticals Inc. is the outcome of the acquisition by Concordia International Corp of the AMCo group. The group of talents is highly complementary and it has fueled the considerable growth of Advanz Pharma over the last few years. This parent company plans to continue this trend of acquiring more brands to build a truly global pharmaceutical company.